Fundamentals-based quality & risk · not a recommendation
VITAL scores 30/100 (Avoid) on the Orion Score — weak business quality (35), poor growth (10), weak balance-sheet safety (36) and rich valuation (33). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
45/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹133.9 | ₹4.06 | ₹13.12 | 4.8% |
| FY 2024 | ₹98.27 | ₹-1.3 | ₹2.96 | -2.1% |
| FY 2023 | ₹116.74 | ₹8.05 | ₹14.37 | 11.0% |
| FY 2022 | ₹57.61 | ₹7.9 | ₹11.46 | 18.8% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹181.64 | ₹137.45 | ₹137.72 | ₹81.25 |
| Equity | ₹92.14 | ₹84.34 | ₹89.61 | ₹14.62 |
| Total Debt | ₹48.14 | ₹25.78 | ₹28.8 | ₹36.33 |
| Cash | ₹0.82 | ₹0.49 | ₹30.51 | ₹6.24 |
| Net Debt | ₹47.32 | ₹25.29 | — | ₹30.09 |
| Working Capital | ₹27.07 | ₹21.38 | ₹67.62 | ₹15.5 |
Q2 FY2026
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q2 FY2026 | 73.43% | 1.78% ↑ | 0.25% | 24.54% ↓ |
| Q4 FY2025 | 73.43% | 0.16% ↓ | 0.25% ↓ | 26.16% ↑ |
| Q2 FY2025 | 73.43% | 0.56% ↓ | 0.33% ↓ | 25.68% ↑ |
| Q4 FY2024 | 73.43% | 0.78% ↓ | 0.96% ↓ | 24.83% ↑ |
| Q2 FY2024 | 73.43% ↑ | 3.62% ↓ | 1.81% ↓ | 21.14% ↑ |
| Q4 FY2023 | 73.28% | 6.53% | 4.12% | 16.07% |
No recent corporate actions
Ask: "Is VITAL stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.